<strong>BEKHealth Welcomes David Levin as President and Chief Executive Officer</strong>
BEKHealth Welcomes David Levin as President and Chief Executive Officer
Experienced executive to lead company through its next phase of growth.
Branford, CT, March 23, 2023 – BEKHealth, a leading AI-powered patient-matching technology company serving the clinical trial industry, today announced that David Levin has joined the company as president and chief executive officer. In this role, Levin will lead the company’s strategic direction and growth initiatives.
A 2x CEO and executive at multiple startups, David brings over 25 years of experience as a leader in building clinical research and digital health companies. Levin joins BEKHealth from Crucial Data Solutions, a provider of low-code/no-code clinical data management technology, where he led its marketing as the company’s chief marketing officer. Prior to Crucial Data, Levin served at CEO at RelyMD, a virtual care technology and service provider, and Bivarus, a venture-backed SaaS company that pioneered a novel approach to how healthcare leaders capture and operationalize patient-generated insights, where he led both firms through successful acquisitions.
Prior to Bivarus, David served as global vice president of marketing at Clinipace Worldwide (now known as Caidya), a digital-first contract research organization, where he contributed to the company’s significant growth, leading to the company being recognized as one of the fastest growing private companies in the country, appearing on the INC. 500 list four consecutive years.
“We are thrilled to welcome David Levin to the BEKHealth team,” said Andrew Schwab, chairman of the BEKHealth Board of Directors and managing partner at Excelerate Health Ventures. “After a thorough process, Dave’s extensive experience in both clinical research and healthcare, coupled with his leadership skills, make him the ideal person to lead BEKHealth through its next phase of growth.”
Levin added, “I am excited to join BEKHealth and help drive the company’s mission to expand patient access to clinical research. BEKHealth has an impressive AI-powered patient-matching technology platform and an experienced research services team, and I look forward to working with them to continue to innovate and grow.”
BEKHealth Corporation operates an AI-powered patient-matching software platform serving the clinical trial industry. The platform allows life sciences and healthcare organizations to speed up site selection and patient recruitment by extracting data from electronic medical records (EMRs), which includes structured and unstructured clinical data that captures three times more trial criteria. BEKHealth’s AI-driven data platform uses a proprietary ontology that has been built from 400+ medical libraries aligned against 70,000 protocols to standardize patient data to its interoperable clinical data model. Analyzing records for more than 43 million patients at over 300 partner clinical sites, BEKHealth leverages its extensive knowledge of patient populations to enhance enrollment optimization and detect more protocol-eligible candidates than traditional methods. Given that only 3% of practicing physicians engage in medical research, and less than 9% of patients receive an invitation to participate in clinical trials, BEKHealth’s mission is to enhance human health and well-being by significantly increasing patient access to clinical research. For more information, visit www.bekhealth.com.